Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
UCB SA (UCB BB)
Watchlist
20
Analysis
Health Care
•
Belgium
UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Nippon Shinyaku
•
30 Nov 2022 21:59
Nippon Shinyaku (4516 JP): Viltepso Has Strong Muscle Power; New Seizure Drug Launch in Japan
Strong performance of DMD drug Viltepso in US market and reviving functional food business have enabled the company to raise FY23 guidance. Late...
Tina Banerjee
Follow
404 Views
Share
bullish
•
Eli Lilly & Co
•
07 Apr 2022 01:19
Buy Global LargeCap Pharma: LLY, AZN, NOVO.B-DK, ROG-CH, BMY, BAYN-DE, UCB-BE, IPN-FR, 4528-JP, TEVA
The VanEck Pharmaceutical ETF $PPH recently broke out topside a 9-month base and RS displays a bullish reversal. Zooming-out, we can see a 6+ year...
Vermilion Research
Follow
272 Views
Share
bullish
•
Reliance Industries
•
24 Sep 2021 21:49
Global Energy Sector Improving -- Buying Reliance Industries Ltd, Several Others
Crude oil prices display bullish short-term reversals, resulting in bullish price and RS reversals for global Energy stocks -- add exposure.
Vermilion Research
Follow
420 Views
Share
bullish
•
SK Biopharmaceuticals
•
19 May 2020 22:44
SK Biopharm IPO Preview
SK Biopharmaceuticals (BIO SK) is getting ready to complete an IPO in the Korean stock market in June. The SK Biopharm will be one of the biggest...
Douglas Kim
Follow
235 Views
Share
bearish
•
Samsung Biologics
•
22 Oct 2018 22:52
Samsung BioLogics Update
Recent developments in Samsung Biologics Co., (207940 KS)'s business have been mixed with a negative skew. First, partner Merck & Co Inc (MRK...
Kemp Dolliver, CFA
527 Views
Share
First
Previous
1
2
3
4
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.1
x